Approval · Notice of Compliance 23292 · 2020
REGIOCIT: Notice of Compliance 23292
Issued March 3, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23292
- Date
- March 3, 2020
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REGIOCIT | 02496755 | Marketed |
Medicinal ingredients
- SODIUM CHLORIDE 5.03 G per L
- SODIUM CITRATE 5.29 G per L